Marina Lukas

577 total citations
9 papers, 265 citations indexed

About

Marina Lukas is a scholar working on Hematology, Infectious Diseases and Surgery. According to data from OpenAlex, Marina Lukas has authored 9 papers receiving a total of 265 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Hematology, 3 papers in Infectious Diseases and 2 papers in Surgery. Recurrent topics in Marina Lukas's work include COVID-19 Clinical Research Studies (3 papers), Liver Disease and Transplantation (2 papers) and Platelet Disorders and Treatments (2 papers). Marina Lukas is often cited by papers focused on COVID-19 Clinical Research Studies (3 papers), Liver Disease and Transplantation (2 papers) and Platelet Disorders and Treatments (2 papers). Marina Lukas collaborates with scholars based in Germany, Switzerland and Italy. Marina Lukas's co-authors include Christoph D. Spinner, Tobias Lahmer, Roland M. Schmid, Kathrin Rothe, Michael Dommasch, Matthias Treiber, Dirk H. Busch, Markus Heim, Gerhard Schneider and Christiane Querbach and has published in prestigious journals such as Scientific Reports, Nutrients and Thrombosis and Haemostasis.

In The Last Decade

Marina Lukas

9 papers receiving 259 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marina Lukas Germany 7 114 70 63 42 40 9 265
Raihan Rabbani Bangladesh 9 85 0.7× 73 1.0× 16 0.3× 19 0.5× 34 0.8× 46 316
Justin de Brabander Netherlands 11 53 0.5× 66 0.9× 29 0.5× 24 0.6× 43 1.1× 21 270
Víctor Moreno‐Torres Spain 13 176 1.5× 157 2.2× 19 0.3× 28 0.7× 36 0.9× 59 420
Aurélie Gouél‐Cheron France 12 50 0.4× 120 1.7× 19 0.3× 50 1.2× 67 1.7× 28 391
Kamran Mushtaq Qatar 8 62 0.5× 54 0.8× 11 0.2× 16 0.4× 30 0.8× 37 294
Ludwig Traby Austria 11 66 0.6× 44 0.6× 12 0.2× 9 0.2× 36 0.9× 28 322
Brian Choo‐Kang United Kingdom 9 68 0.6× 67 1.0× 62 1.0× 68 1.6× 31 0.8× 12 483
Laura Jiménez Spain 10 51 0.4× 111 1.6× 14 0.2× 22 0.5× 34 0.8× 15 452
Nour Abidi Belgium 7 33 0.3× 98 1.4× 28 0.4× 48 1.1× 14 0.3× 8 334
Sophie Roth Germany 6 43 0.4× 53 0.8× 14 0.2× 13 0.3× 13 0.3× 16 410

Countries citing papers authored by Marina Lukas

Since Specialization
Citations

This map shows the geographic impact of Marina Lukas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marina Lukas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marina Lukas more than expected).

Fields of papers citing papers by Marina Lukas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marina Lukas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marina Lukas. The network helps show where Marina Lukas may publish in the future.

Co-authorship network of co-authors of Marina Lukas

This figure shows the co-authorship network connecting the top 25 collaborators of Marina Lukas. A scholar is included among the top collaborators of Marina Lukas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marina Lukas. Marina Lukas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Lukas, Marina. (2023). Myelodysplastische Syndrome: Was hat sich bei der Therapie getan?. MMW - Fortschritte der Medizin. 165(1). 43–45. 1 indexed citations
2.
Lazareva, Olga, Marc Rosenbaum, Marina Lukas, et al.. (2021). Platelet Surface Protein Expression and Reactivity upon TRAP Stimulation after BNT162b2 Vaccination. Thrombosis and Haemostasis. 122(10). 1706–1711. 10 indexed citations
3.
Bongiovanni, Dario, Olga Lazareva, Simona Ursu, et al.. (2021). SARS-CoV-2 infection is associated with a pro-thrombotic platelet phenotype. Cell Death and Disease. 12(1). 50–50. 71 indexed citations
4.
Rothe, Kathrin, Susanne Feihl, Jochen Schneider, et al.. (2020). Rates of bacterial co-infections and antimicrobial use in COVID-19 patients: a retrospective cohort study in light of antibiotic stewardship. European Journal of Clinical Microbiology & Infectious Diseases. 40(4). 859–869. 94 indexed citations
5.
Lukas, Marina, Britta Velten, Leopold Sellner, et al.. (2020). Survey of ex vivo drug combination effects in chronic lymphocytic leukemia reveals synergistic drug effects and genetic dependencies. Leukemia. 34(11). 2934–2950. 17 indexed citations
6.
Mayr, Ulrich, Marina Lukas, Livia Habenicht, et al.. (2020). B-Lines Scores Derived From Lung Ultrasound Provide Accurate Prediction of Extravascular Lung Water Index: An Observational Study in Critically Ill Patients. Journal of Intensive Care Medicine. 37(1). 21–31. 26 indexed citations
7.
Mayr, Ulrich, Marina Lukas, Ulrike Bauer, et al.. (2020). NUTRIC and Modified NUTRIC are Accurate Predictors of Outcome in End-Stage Liver Disease: A Validation in Critically Ill Patients with Liver Cirrhosis. Nutrients. 12(7). 2134–2134. 19 indexed citations
8.
Mayr, Ulrich, Marina Lukas, Christine A. Vogt, et al.. (2020). Ascitic Interleukin 6 Is Associated with Poor Outcome and Spontaneous Bacterial Peritonitis: A Validation in Critically Ill Patients with Decompensated Cirrhosis. Journal of Clinical Medicine. 9(9). 2865–2865. 6 indexed citations
9.
Lee, Kwang Seok, Jennifer Hüllein, Marina Lukas, et al.. (2018). Drug-based perturbation screen uncovers synergistic drug combinations in Burkitt lymphoma. Scientific Reports. 8(1). 12046–12046. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Raihan Rabbani Breakdown of academic impact, for papers by Justin de Brabander Breakdown of academic impact, for papers by Víctor Moreno‐Torres Breakdown of academic impact, for papers by Aurélie Gouél‐Cheron Breakdown of academic impact, for papers by Kamran Mushtaq Breakdown of academic impact, for papers by Ludwig Traby Breakdown of academic impact, for papers by Brian Choo‐Kang Breakdown of academic impact, for papers by Laura Jiménez Breakdown of academic impact, for papers by Nour Abidi Breakdown of academic impact, for papers by Sophie Roth
Rankless by CCL
2026